- Home
- IPWR vs ONCY Comparison
IPWR vs ONCY Comparison
Compare IPWR & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPWR
- ONCY
- Stock Information
- Founded
- IPWR 2007
- ONCY 1998
- Country
- IPWR United States
- ONCY Canada
- Employees
- IPWR N/A
- ONCY N/A
- Industry
- IPWR Industrial Machinery/Components
- ONCY Pharmaceuticals and Biotechnology
- Sector
- IPWR Industrials
- ONCY Health Care
- Exchange
- IPWR Nasdaq
- ONCY Nasdaq
- Market Cap
- IPWR 42.1M
- ONCY 49.1M
- IPO Year
- IPWR 2013
- ONCY 1999
- Fundamental
- Price
- IPWR $4.70
- ONCY $0.92
- Analyst Decision
- IPWR Hold
- ONCY Strong Buy
- Analyst Count
- IPWR 1
- ONCY 4
- Target Price
- IPWR N/A
- ONCY $4.33
- AVG Volume (30 Days)
- IPWR 63.9K
- ONCY 1.4M
- Earning Date
- IPWR 08-13-2025
- ONCY 07-31-2025
- Dividend Yield
- IPWR N/A
- ONCY N/A
- EPS Growth
- IPWR N/A
- ONCY N/A
- EPS
- IPWR N/A
- ONCY N/A
- Revenue
- IPWR $19,296.00
- ONCY N/A
- Revenue This Year
- IPWR N/A
- ONCY N/A
- Revenue Next Year
- IPWR $5,900.00
- ONCY N/A
- P/E Ratio
- IPWR N/A
- ONCY N/A
- Revenue Growth
- IPWR N/A
- ONCY N/A
- 52 Week Low
- IPWR $3.77
- ONCY $0.33
- 52 Week High
- IPWR $9.69
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- IPWR 53.15
- ONCY 78.48
- Support Level
- IPWR $3.81
- ONCY $0.71
- Resistance Level
- IPWR $4.77
- ONCY $0.81
- Average True Range (ATR)
- IPWR 0.38
- ONCY 0.09
- MACD
- IPWR 0.05
- ONCY 0.02
- Stochastic Oscillator
- IPWR 85.58
- ONCY 89.43
About IPWR Ideal Power Inc.
Ideal Power Inc is pioneering the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.